- Home
- SUPN vs BANC Comparison
SUPN vs BANC Comparison
Compare SUPN & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | BANC |
|---|---|---|
| Founded | 2005 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | SUPN | BANC |
|---|---|---|
| Price | $49.74 | $19.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $61.60 | $20.06 |
| AVG Volume (30 Days) | 634.2K | ★ 1.7M |
| Earning Date | 11-04-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | $681,539,000.00 | ★ $1,019,965,000.00 |
| Revenue This Year | $8.32 | $6.10 |
| Revenue Next Year | $23.36 | $10.89 |
| P/E Ratio | ★ N/A | $19.08 |
| Revenue Growth | 4.54 | ★ 147.22 |
| 52 Week Low | $29.16 | $11.52 |
| 52 Week High | $57.65 | $20.17 |
Technical Indicators
Market Signals| Indicator | SUPN | BANC |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 57.62 |
| Support Level | $51.01 | $19.51 |
| Resistance Level | $52.30 | $19.77 |
| Average True Range (ATR) | 1.40 | 0.37 |
| MACD | 0.35 | -0.10 |
| Stochastic Oscillator | 64.48 | 35.96 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.